Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$85,560,146
+$21,007,929 QoQ
Shares Held
71,334
+1.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.83%
of 13F equity value
Holder Rank
#414
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $216,358,127 across 7 Drug Manufacturers - General names. LLY ranks #2 (39.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
506,085 | $95,963,837 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
71,334 | $85,560,146 | |
| 3 | ABBV |
AbbVie Inc.
|
44,477 | $11,192,192 | |
| 4 | PFE |
Pfizer Inc
|
439,717 | $10,588,385 | |
| 5 | AMGN |
Amgen Inc
|
19,011 | $6,884,263 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,368 | $3,305,544 | |
| 7 | GRFS |
Grifols SA
|
404,486 | $2,863,760 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,560,146 | 71,334 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $64,552,217 | 70,183 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $78,706,346 | 73,237 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $52,448,620 | 68,740 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $55,906,332 | 71,718 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $59,775,236 | 72,375 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $53,059,560 | 68,730 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $59,105,487 | 66,715 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $61,509,706 | 67,938 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $56,373,315 | 72,463 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $58,283,256 | 99,985 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $54,832,916 | 102,085 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $47,888,016 | 102,111 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $36,545,039 | 106,415 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $38,793,307 | 106,039 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $34,023,210 | 105,221 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $32,443,102 | 100,062 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,168,442 | 49,476 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $9,499,758 | 34,392 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,477,948 | 28,037 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,509,416 | 28,361 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,287,006 | 28,300 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $1,335,880 | 9,025 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,457,261 | 8,876 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,967,636 | 21,393 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||